Kennedy Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
2,628
-43
-2% -$43.6K 0.95% 24
2025
Q4
$2.87M Sell
2,671
-121
-4% -$116K 1.08% 23
2025
Q3
$2.13M Buy
2,792
+9
+0.3% +$6.7K 0.85% 27
2025
Q2
$2.17M Sell
2,783
-49
-2% -$38.1K 0.92% 26
2025
Q1
$2.34M Buy
2,832
+283
+11% +$235K 1.09% 21
2024
Q4
$1.97M Buy
2,549
+472
+23% +$391K 0.89% 27
2024
Q3
$1.84M Buy
2,077
+208
+11% +$187K 0.85% 28
2024
Q2
$1.69M Buy
1,869
+48
+3% +$38.4K 0.86% 28
2024
Q1
$1.42M Buy
1,821
+301
+20% +$214K 0.76% 36
2023
Q4
$886K Buy
1,520
+202
+15% +$118K 0.5% 55
2023
Q3
$708K Sell
1,318
-18
-1% -$9.28K 0.43% 66
2023
Q2
$627K Sell
1,336
-5
-0.4% -$2.1K 0.37% 71
2023
Q1
$460K Sell
1,341
-45
-3% -$15.2K 0.28% 82
2022
Q4
$507K Buy
+1,386
New +$491K 0.32% 76

Other funds holding LLY

Kennedy Investment Group's LLY Position: Q1 2026 in Review

Kennedy Investment Group reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $43.6K and leaving 2,628 shares worth $2.42M. The position accounts for 0.95% of the portfolio, ranked #24.

Kennedy Investment Group first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.87M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kennedy Investment Group held 2,628 shares of Eli Lilly worth $2.42M as of Q1 2026.
  • Kennedy Investment Group sold 43 Eli Lilly shares in Q1 2026, an estimated $43.6K.
  • Eli Lilly made up 0.95% of Kennedy Investment Group's portfolio in Q1 2026, its #24 holding.
  • Kennedy Investment Group first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Kennedy Investment Group's Eli Lilly position peaked at $2.87M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kennedy Investment Group's 13F filing for Q1 2026, filed 22 Apr 2026.